Forum programme

Download the Eighth EDCTP Forum Programme and Abstract book (PDF)

Download the Eighth EDCTP Forum programme at a glance (Last update: 26 October 2016)

This year’s Forum programme will comprise of a wide range of topics of clinical research covering poverty-related and neglected infectious diseases within the scope of the EDCTP programme.


  • Sunday 6 Nov 2016
  • Monday 7 Nov 2016
  • Tuesday 8 Nov 2016
  • Wednesday 9 Nov 2016

17:00-19:30 Plenary session I Main auditorium
Chair: Michael Makanga (The Netherlands)  
17:15-18:30 Welcome address and opening of the Eighth EDCTP Forum  
His Excellency Mr Edgar Chagwa Lungu, President of the Republic of Zambia

Mark Palmer, Chair of the EDCTP Association (United Kingdom)

Line Matthiessen, European Commission

Leonardo Simão, EDCTP High Representative

18:30-19:30 R&D to tackle global health challenges: roles and responsibilities for EDCTP  
Marcel Tanner, EDCTP High Representative  
19:30-19:40 Award ceremony Main auditorium
Outstanding Research Team award  
19:40-21:00 Welcome reception Banquet hall

07:45-08:45 Workshop Conference room 1
Applying for an EDCTP2 grant  
Organisers: EDCTP and Fit for Health 2.0  
09:00-10:30 Plenary session II Main auditorium
Chairs: Christiane Druml (Austria) and Peter Mwaba (Zambia)  
09:00-09:45 EDCTP2 vision and strategy

Michael Makanga, EDCTP (The Netherlands)

09:45-10:30 Evidence-informed policy making

Jimmy Volmink, Stellenbosch University (South Africa)

10:30-11:00 Coffee break Foyer
11:00-12:30 Plenary session III Main auditorium
Chairs: Nkando Luo (Zambia) and Ole Olesen (Netherlands))  
HIV and tuberculosis: status update, key research questions and role of EDCTP2  
11:00-11:45 HIV: Catherine Hankins, Amsterdam Institute for Global Health and Development (The Netherlands)  
11:45-12:30 Tuberculosis: Christian Lienhardt, WHO (Switzerland)  
12:30-16:00 High-level meeting of African and European policy makers (invitation only) Conference room 8
12:30-14:00 Lunch Banquet hall
12:45-13:45 Collaborative session Conference room 1
Coming together to support scientists in low-and middle-income countries: partnering among funders to achieve impact  
12:45-13:45 Workshop Conference room 2
Supporting prospective clinical trial data collection  
WorldWide Antimalarial Resistance Network (WWARN)  
12:30-14:00 Poster presentations A – malaria Foyer
Scientific symposia  
14:00-16:00 Using systematic reviews to inform policy and research direction on neglected disease

Cochrane Centre (South Africa)

Conference room 1
14:00-16:00 Leveraging Partnerships to Advance Product Development and Build Research Capacity

Bioventures for Global Health (USA)

Conference room 2
14:00-16:00 Importance of blood-stage malaria vaccine candidates in the development of a next generation malaria vaccine

European Vaccine Institute (Germany)

Conference room 3
14:00-16:00 Tuberculosis: shorter and better treatments on the horizon

PanACEA Consortium and Medical Center of the University of Munich (Germany)

Conference room 4
16:00-16:30 Coffee break Foyer
16:30-17:30 Plenary session IV Main auditorium
Chairs: Hannah Akuffo (Sweden) and Christian Burri (Switzerland)  
Panel discussion:

Supporting clinical research in Africa: Needs, priorities and role of public and private sectors

Wim Parys, Janssen (Belgium)

Golbahar Pahlavan, Pasteur Center for Global Health (France)

Peter Mwaba, Permanent Secretary, Ministry of Health, (Zambia)

Morven Roberts, Medical Research Council (UK)

17:30-17:45 Award ceremony Main auditorium
Scientific Leadership award  
18:00-19:00 Satellite meeting Conference room 3
  New diagnosis and AMR control tools for newborns and infants presenting diarrhoea  
bioMérieux (France)  
19:30-21:30 Conference dinner  

07:45-08:45 Workshop Conference room 1
Grant agreement preparation with EDCTP2  
EDCTP and Fit for Health 2.0 (Germany)  
09:00-10:30 Plenary session V Main auditorium
  Chairs: Moses Bockarie (South Africa) and Francine Ntoumi (Republic of Congo)  
09:00-09:45 Malaria and neglected infectious diseases: status update, key research questions and role of EDCTP2  
09:45-10:30 Malaria: Abdisalan Noor, WHO (Switzerland)

Neglected Infectious Diseases: Nathalie Strub Wourgaft, Drugs for Neglected Diseases initiative (Switzerland)

10:30-11:00 Coffee break Foyer
Parallel session  
11:00-12:30 Ethics & regulatory activities Conference room 1
Chairs: Maria Fraga Oliveira Martins (Portugal) and Jean Marie Talom (Cameroon)  
The added value of a multi-country network for promoting ethical and regulatory standards in clinical trials in low- and middle-income countries: the experience of the Switching the Poles network

Raffaella Ravinetto, Institute of Tropical Medicine (Belgium)

Translating ethics guidelines on compensation for research-related injuries into policy in low-income countries: lessons learnt from Malawi

Patrick Dongosolo Kamalo, College of Medicine, University of Malawi (Malawi)

Improving the Efficiency of African Research Ethics Committees and Standardizing Ethics Review processes – through an Automated review platform

Boitumelo Mokgatla, International AIDS Vaccine Initiative (South Africa)

Development and evaluation of a multimedia tool for obtaining informed consent in The Gambia: a mixed method study

Muhammed Olanrewaju Afolabi, Medical Research Council Unit (The Gambia)

11:00-12:30 Tuberculosis Conference room 2
Chairs: Maryline Bonnet (France) and Ali Zumla (UK)  
Optimizing Clinical Outcomes in HIV-Infected Adults Using Xpert MTB/RIF and Lipoarabinomannan in Zambia

Margaret Phiri Kasaro, Center for Infectious Disease Research in Zambia and University of Alabama at Birmingham (Zambia)

Comparative evaluation of GenoType MTBDRplus Version 2 and Gene Xpert MTB/RIF assays to detect Mycobacterium tuberculosis and resistance gene patterns in Gabon

Abraham Alabi, Centre de Recherches Medicales de Lambaréné (Gabon)

Molecular bacterial load assay: a fast and accurate means for monitoring tuberculosis (TB) treatment response

Wilber Sabiiti, University of St. Andrews (United Kingdom)

Early biomarkers associated with progression of Latent Tuberculosis Infection to clinically active disease and patients treatment success

Niaina Rakotosamimanana, Antananarivo Institut Pasteur de Madagascar (Madagascar)

11:00-12:30 Neglected Infectious Diseases Conference room 3
Chairs: Michelle Helinski (Netherlands) and Thomas Nyirenda (South Africa)  
Diagnostic tools for human African trypanosomiasis elimination and clinical trials: the DiTECT-HAT project

Veerle Lejon, Institut de Recherche pour le Développement (France)

Prevalence and clinical significance of schistosomiasis-chronic hepatitis B virus co-infection in Zambia

Caroline Cleopatra Chisenga, Centre for Infectious Disease Research (Zambia)

The immune Trypanolysis test: an accurate serological marker to manage elimination of gambiense human African trypanosomiasis

Dama Emilie, Université Polytechnique de Bobo-Dioulasso (UPB)/ Centre International de Recherche-Développement sur l’Elevage en zone Subhumide (France)

11:00-12:30 Scientific symposia Conference room 4
Attenuated sporozoite-based vaccines for malaria  
University of Tübingen (Germany)  
12:30-14:00 Lunch Banquet hall
12:30-13:30 Meet the experts Banquet hall
12:45-13:45 Workshop  
ISO-accreditation for sub-Saharan African laboratories

Q2 Solutions (South Africa)

Conference room 1
12:45-13:45 Higher Education and innovation in public health Conference room 2
Institut Pasteur (France)  
12:45-13:45 Announcement Conference room 3
Birth Day Prize  
12:30-14:00 Poster presentations B – HIV and TB Foyer
Parallel session Conference room 1
14:00-16:00 HIV  
Chairs: Knut Fylkesnes (Norway) and Marie-Louise Newell (UK)  
Prevalence and risk factors of virological failure among paediatric children on antiretroviral therapy

Michael Owusu, Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana

Virological response to early combined antiretroviral therapy in HIV-infected infants: evaluation after 2 years of treatment in the PEDIACAM study, Cameroon

Francis Ndondo, Chantal Biya Foundation (Cameroon)

HIV infection and cardiovascular risk profile in a rural South-African population. The Ndlovu Cohort Study

Alinda Vos, University Medical Center Utrecht, Julius Center (The Netherlands)

Phylogenetic and Demographic Characterization of HIV-1 Transmission Networks in a General Population Cohort in Uganda

Deogratius Ssemwanga, MRC/UVRI Uganda Research Unit on AIDS (Uganda)

Prevalence and risk factors for efavirenz-based antiretroviral treatment associated severe vitamin D deficiency: A prospective cohort study

Eleni Aklillu, Karolinska Institute (Sweden)

Scientific symposia  
14:00-16:00 Strong local research leading to evidence-informed policies in Africa

NACCAP (Netherlands)

Conference room 2
14:00-16:00 Post registration safety and efficacy monitoring on new antimalarial treatments

Medicines for Malaria Venture (Switzerland) and West African Network for Clinical Trials of Antimalarial Drugs (Mali)

Conference room 3
14:00-16:00 Maximising EDCTP membership: how to catalyse national efforts and converge EU and African Global Health efforts

Deutsche Stiftung Weltbevoelkerung (DSW, Germany)

Conference room 4
16:00-16:30 Coffee break Foyer
16:30-17:30 Plenary session VI Main auditorium
Chairs: John Gyapong (Ghana) and Line Matthiessen (European Commission)  
Panel discussion:

Is Africa prepared for epidemics? Lessons learnt from the Ebola epidemic

Rashid Ansumana, Mercy Hospital (Sierra Leone)

Noel Tordo, Institut Pasteur (Guinea)

Fatorma Bolay, Liberian Institute for Biomedical Research, (Liberia)

17:30-17:45 Award ceremony Main auditorium
Outstanding Female Scientist award  
18:00-20:00 Scientific symposia Conference room 1
Clinical research in Zambia

Ministry of Health, (Zambia)

18:00-20:00 Satellite session: Conference room 2
Building an innovation ecosystem for global health  
Johnson & Johnson (USA)  

08:30-10:0 Plenary session VII Main auditorium
Chairs: Clara Menendez (Spain, Mozambique) and Charles Mgone (Tanzania)  
08:30-09:15 Innovative clinical trial designs  
Patrick Phillips, MRC Clinical Trials Unit at UCL (United Kingdom)  
09:15-10:00 Panel discussion:

Implementation of new interventions: experience from the field

Main auditorium
Jeremiah Chakaya, KEMRI (Kenya)

Veronica Mulenga, UTH (Zambia)

Jean Marie Talom, REDS (Cameroon)

10:00-10:30 Coffee break Foyer
Parallel session Conference room 1
10:30-12:00 Diarrhoeal diseases  
Chairs: Jeffrey Mphahlele (South Africa) and Shingai Machingaidze (South Africa)  
Vibrio cholerae endemic in Mozambique based on multilocus variable number tandem repeat analysis and whole genome sequencing

Marcelino Garrine, Centro de Investigação em Saúde de Manhiça (Mozambique)

The burden and future scope for important viral enteric pathogens in Africa 

Duncan Steele, Gates Foundation (United States)

New possibilities for the development of a combined vaccine against ETEC and Shigella

Richard Walker, PATH (USA)

Impact of targeted interventions against diarrhoea in Zambia

Roma Chilengi, Center for Infectious Disease Research, Zambia

10:30-12:00 NIDs and emerging infectious diseases Conference room 2
Chairs: John Gyapong (Ghana) and Jean Marie Habarugira (Netherlands)  
Point-of-Need diagnostics: Biosurveillance with a Device2Cloud capability in Sierra Leone

Rashid Ansumana, Mercy Hospital, Sierra Leone

Safety and Immunogenicity of Co-administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 with Alhydrogel® and Glucopyranosyl-Lipid A in Gabonese adults: Interim Results

Ayola Akim Adegnika, Centre de Recherches Médicales de Lambaréné (Gabon)

One-year Safety of the rVSV G-ZEBOV-GP vaccine in adolescents and children in Lambaréné, Gabon

Bache Bache, Centre de Recherches Médicales de Lambaréné (Gabon)

Clinical trials for elimination of NTDs amenable to mass drug administration

Moses Bockarie, EDCTP (South Africa)

10:30-12:00 Malaria Conference room 3
Chairs: Montserrat Blazquez-Domingo (Netherlands) and Sodiomon Sirima (Burkina Faso)  
Artemisinin-based Combination Treatments in Pregnant Women in Zambia: Efficacy, Safety and Risk of Recurrent Malaria

Michael Nambozi, Tropical Diseases Research Center (Zambia)

The effect of Artemisinin-based Combination Therapy (ACT) options on hematological response in Plasmodium falciparum malaria: a systematic review and pooled analysis of individual patient data

Georgina Humphreys on behalf of WWARN Malnutrition Study Group, University of Oxford (United Kingdom)

MDA Integrated Malaria Elimination in a Hypo Endemic Island in Lake Victoria, Kenya

Jesse Gitaka, Mount Kenya University (Kenya)

Randomized trial to assess effect of repeated treatment of DHA-PQ and AL on QTc interval in patients presenting with uncomplicated malaria in Bobo-Dioulasso, Burkina Faso

Naomie T Kabore, IRSS/DRO, Bobo Dioulasso (Burkina Faso)

Patterns of molecular markers of resistance in “real life” repetitive dihydroartemisinin-piperaquine malaria treatment: a molecular analysis of the WANECAM clinical trial platform output

Jose Pedro Gil, Karolinska Institutet (Sweden)

10:30-12:00 Vaccine development (HIV and TB) Conference room   4
Chairs: Stefan Kaufmann (Germany) and Gita Ramjee (South Africa)  
Immunogens designed for targeting neutralizing epitopes of HIV-1 envelope glycoprotein

Godwin Nchinda, CIRCB (Cameroon)

  Progress in the development of safe and effective tuberculosis vaccines

Dereck Tait, Aeras (South Africa)

  Community engagement in TB vaccine research and development in Zambia

Olga Manda, ZAMBART, Zambia

  The results of the EV06 DNA-Protein combination trial and plans for GREAT an EDCTP2 funded conserved-mosaic epitope HIV vaccine trial. Pontiano Kaleebu, UVRI, Uganda  
12:00-13:30 Lunch Banquet hall
12:30-13:30 Meet the experts  
12:15-13:15 Workshop Conference room 1
From research to publication

BMJ (United Kingdom)

12:15-13:15 Satellite meeting  
Can mobile health increase funds for healthcare and improve access to high quality care?

Joep Lange Institute (Netherlands)

Leveraging partnerships, capacity-building, and funding to advance neglected infectious disease product development

BIO Ventures for Global Health (BVGH)

Conference room 2

                                                                                                Conference room 3

12:00-13:30 Poster presentations C – NTDs, emerging infections & cross cutting themes Foyer
13:30-15:00 Plenary session VIII Main auditorium
Chairs: Christine Manyando (Zambia) and Salim Abdulla (Tanzania)  
13:30-14:15 Improving maternal and child health through community engagement in clinical trials

Khatia Munguambe, Universidade Eduardo Mondlane & Centro de Investigação em Saúde da Manhiça (Mozambique)

14:15-15:00 Panel discussion:

Building research capacity in Africa

Evelyn Gitau, AESA (Kenya)

Núria Casamitjana Badia, ISGlobal (Spain)

Soulemayne Mboup, UCAD (Senegal)

15:00-15:30 Coffee break Foyer
15:30-16:00 Award ceremony Main auditorium
Dr Pascoal Mocumbi Prize  
16:00-16:30 Summary and future directions

Chief rapporteur

16:30-17:00 Closing session  
Michael Makanga, EDCTP Executive Director

Leonardo Simão, EDCTP High Representative

Honorable Minister of Health of the Republic of Zambia, Dr Chitalu Chilufya, MP